## Molecular Mechanism and Rationale
The archived hypothesis centers on targeting the gamma-secretase complex modulation pathway as a disease-modifying therapeutic approach for Alzheimer's disease (AD). Gamma-secretase represents a critical enzymatic complex comprising four essential subunits: presenilin-1 (PSEN1) or presenilin-2 (PSEN2) as the catalytic core, nicastrin (NCT) as the substrate receptor, anterior pharynx-defective 1 (APH1), and presenilin enhancer 2 (PEN2) as stabilizing componen
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.00
Evidence
0.45
Novelty
0.00
Feasibility
0.00
Impact
0.00
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.00
Reproducible
0.00
KG Connect
0.50
Score Breakdown
Dimension
[Archived Hypothesis]
Mechanistic
0.000
Evidence
0.450
Novelty
0.000
Feasibility
0.000
Impact
0.000
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.000
Reproducible
0.000
KG Connect
0.500
Evidence
[Archived Hypothesis]
No evidence citations yet
Debate Excerpts
[Archived Hypothesis]
4 rounds · quality: 0.81
Theorist
# Legacy Pre-Pipeline Hypotheses: Neurodegeneration
---
## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease
**Mechanism:** Misfolded α-synuclein (aSy...
Skeptic
# Critical Evaluation of Legacy Pre-Pipeline Hypotheses
## General Methodological Concerns (Cross-Cutting Issues)
Before evaluating individual hypotheses, several systemic weaknesses affect the enti...
Domain Expert
# Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses
## Preamble
This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease",
"description": "TREM2 loss-of-function variants ...